AHR and fungal lung infectious disease: reported that both AhR agonist Kyn and AhR antagonist CH223191 decreased the number of Th1 cells in a mice pulmonary fungal infection model, while agonist FICZ resulted in the expansion of all CD4+ T cell subsets (Th1, Th2, Th17, Th22, and Treg) (65).